Cite
HARVARD Citation
Capuccini, J. et al. (n.d.). PO-0737: Adjuvant hormone therapy in intermediate-high risk prostate cancer: LH-RH agonist versus anti-androgens. Radiotherapy and oncology. pp. S365-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Capuccini, J. et al. (n.d.). PO-0737: Adjuvant hormone therapy in intermediate-high risk prostate cancer: LH-RH agonist versus anti-androgens. Radiotherapy and oncology. pp. S365-. [Online].